Hotchkis & Wiley Capital Management LLC grew its holdings in ProAssurance Co. (NYSE:PRA - Free Report) by 11.1% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 484,040 shares of the insurance provider's stock after buying an additional 48,290 shares during the period. Hotchkis & Wiley Capital Management LLC owned 0.95% of ProAssurance worth $7,280,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Deerfield Management Company L.P. Series C raised its stake in ProAssurance by 199.4% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 80,425 shares of the insurance provider's stock valued at $983,000 after acquiring an additional 53,560 shares during the last quarter. Allspring Global Investments Holdings LLC raised its stake in shares of ProAssurance by 1.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,311,435 shares of the insurance provider's stock worth $19,724,000 after purchasing an additional 18,718 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of ProAssurance by 402.1% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 68,435 shares of the insurance provider's stock worth $1,029,000 after purchasing an additional 54,806 shares during the period. Assenagon Asset Management S.A. grew its position in ProAssurance by 2.4% in the 2nd quarter. Assenagon Asset Management S.A. now owns 253,649 shares of the insurance provider's stock valued at $3,100,000 after buying an additional 6,062 shares during the last quarter. Finally, Public Sector Pension Investment Board raised its position in ProAssurance by 6.1% during the 2nd quarter. Public Sector Pension Investment Board now owns 112,203 shares of the insurance provider's stock worth $1,371,000 after buying an additional 6,437 shares during the last quarter. Institutional investors and hedge funds own 85.58% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on PRA shares. Truist Financial lifted their target price on shares of ProAssurance from $14.00 to $18.00 and gave the company a "hold" rating in a report on Tuesday, November 12th. StockNews.com cut ProAssurance from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Finally, Piper Sandler cut ProAssurance from an "overweight" rating to a "neutral" rating and set a $18.00 price target for the company. in a report on Monday, November 11th. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $18.67.
Read Our Latest Stock Report on ProAssurance
ProAssurance Price Performance
PRA stock traded up $0.48 during trading on Thursday, reaching $17.23. 209,947 shares of the company were exchanged, compared to its average volume of 279,770. ProAssurance Co. has a 52-week low of $10.76 and a 52-week high of $17.79. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. The company has a market cap of $881.49 million, a P/E ratio of 20.17 and a beta of 0.28. The stock's 50 day moving average price is $15.72 and its 200 day moving average price is $13.90.
ProAssurance Company Profile
(
Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Stories
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.